Rhythm Pharmaceuticals, Inc. (RYTM) Q3 2022 Earnings Call Transcript

Rhythm Pharmaceuticals, Inc. (NASDAQ:NASDAQ:RYTM) Q3 2022 Earnings Conference Call November 8, 2022 8:00 AM ET Company Participants David Connolly - Investor Relations and Corporate...

Related Keywords

Marshfield ,Newport ,United Kingdom ,Germany ,United States ,Netherlands ,Israel ,Argentina ,Lasarte ,Pais Vasco ,Spain ,Italy ,Boston ,Massachusetts ,Sweden ,France ,Berlin ,America ,Dave Connolly ,Peter Kennan ,Yann Mazabraud ,Michael Higgins ,Sadaf Farooqi ,Corinne Jenkins ,David Meeker ,Jennifer Chien ,Philip Nadeau ,David Connolly ,Hunter Smith ,Morgan Stanley ,Company Participants ,Corporate Communications At Rhythm Pharmaceuticals ,Head Of International ,University Medical Center ,Goldman Sachs ,European Rare Disease Center ,Nasdaq ,Needham Company ,Rhythm Pharmaceuticals Inc ,Corporate Communications ,Patient Association ,Rhythm Pharmaceuticals Third Quarter ,Rhythm Pharmaceuticals ,Conference Call November ,Chief Executive ,Vice President ,Investor Relations ,Chief Executive Officer ,Executive Vice President ,North America ,Chief Financial Officer ,Rhythm Intune ,Bardet Biedl Syndrome ,Professor Sadaf Farooqi ,Cambridge United Kingdom ,European Commission ,Professor Peter Kennan ,Professor Martin Habit ,Healthcare Royalty Partners ,Dae Gon ,Maybei Ll ,Joseph Stringer ,Jeff Hung ,